13 commercial studies were submitted to NUH R&D in the past 60 days. The median time from validation of the application to R&D approval at NUH was 44.5 days.
“Congratulations on recruiting your first two patients into this trial. You have achieved the First Patient First Treatment (FPFT) in the UK for this trial. Well done.” – Clinical Project Leader
“I just wanted to drop you a note to say thank you so much for our first UK patient. I knew you would be the site that would be able to help us meet this important milestone, this is a great achievement that has been recognised through the business, so many thanks. We really appreciate everything you, the team and R&D have done to finalise the set up of the study.” – CRA Centre Advisor